Subacute sclerosing panencephalitis overview

Subacute sclerosing panencephalitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Subacute sclerosing panencephalitis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Subacute sclerosing panencephalitis overview On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Subacute sclerosing panencephalitis overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Subacute sclerosing panencephalitis overview
CDC on Subacute sclerosing panencephalitis overview
Subacute sclerosing panencephalitis overview in the news
Blogs on Subacute sclerosing panencephalitis overview
Directions to Hospitals Treating Subacute sclerosing panencephalitis
Risk calculators and risk factors for Subacute sclerosing panencephalitis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Subacute sclerosing panencephalitis is a rare chronic, progressive encephalitis that affects primarily children and young adults, caused by defective measles virus (which can be a result of a mutation of the virus itself). 1 in 100,000 people infected with measles are at risk. SSPE is 'incurable' but the condition can be managed by medication if treatment is started at an early stage. Much of the work on SSPE has been completed by the NINDS.